Photodynamic therapy with methyl aminolevulinate: A guideline for practical use;Fotodynamische therapie met methylaminolevulinaat: Een leidraad voor uitvoering van de behandeling

Nederlands Tijdschrift voor Dermatologie en Venereologie

Volumn 14, Issue 8, 2004, Pages 299-306

  Beljaards, R C ^a   Pavel, S ^b  

^a Afdeling Dermatologie   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; FLUOROURACIL; KERATOLYTIC AGENT; PHOTOSENSITIZING AGENT; POLYURETHAN; PROTOPORPHYRIN; SALICYLIC ACID;

ACTINIC KERATOSIS; APPARATUS; BASAL CELL CARCINOMA; CANCER SIZE; CANCER SURGERY; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; COST UTILITY ANALYSIS; CRYOSURGERY; DERMATOLOGY; DRUG EFFICACY; HEALTH CARE COST; HUMAN; MEDICAL LITERATURE; MONEY; NETHERLANDS; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; REVIEW; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 6344229511     PISSN: 09258604     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Von Tappeiner H, Jesionek A. Therapeutische Versuche mit fluorescierenden Stoffen. Munch Med Wochenschr 1903;47:2042-4.
2. Davies MJ. Singlet oxygen-mediated damage to proteins and its consequences. Biochem Biophys Res Commun 2003;305:761-70.
3. Liu Z, Lu Y, Lebwohl M, Wei H. PUVA (8-methoxy-psoralen plus ultraviolet A) induces the formation of 8-hydroxy-2′-deoxyguanosine and DNA fragmentation in calf thymus DNA and human epidermoid carcinoma cells. Free Rad Biol Med 1999;27:127-33.
4. Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 1998;150 (suppl.):146-56
5. Prignano F, Bioanch B, Domenici L, et al. Early apoptosis plays an important role in the healing mechanisms of cutaneous basal cell carcinomas after photodynamic therapy. Br J Dermatol 2003;149:205-6.
6. Oberdanner CB, Kiesslich T, Krammer B, Plaetzer K. Glucose is required to maintain high ATP-levels for the energy-utilizing steps during PDT-induced apoptosis. Photochem Photobiol 2002;76:695-703.
7. Matsuyama A, Nakano H, Harada K, et al. Enhancement of photodynamic effect in normal rat keratinocytes by treatment with 1,25-dihydroxyvitamin D3. Photodermatol Photoimmunol Photomed 2003;19:303-8.
8. Carraro C, Pathak MA. Studies on the nature of in vitro and in vivo photosensitization reactions by psoralens and porphyrins. J Invest Dermatol 1988;90:267-75.
9. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporhyrin IX: basic principle and present clinical experience. J Photochem Photobiol Biol 1990;6:143-8.
10. Szeimies R-M, Landthaler M. Photodynamic therapy and fluorescence diagnosis of skin cancers. Recent Results Cancer Res 2002;160:240-5.
11. Ericson MB, Sandberg C, Gudmundson F, Rosén A, Larko O, Wennberg A-M. Fluorescence contrast and threshold limit: implications for photodynamic diagnosis of basal cell carcinoma. J Photochem Photobiol Biol 2003;69:121-7.
12. Kloek J, Akkermans W, Beiersbergen van Henegouwen GMJ. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporfyrin. Photochem Photobiol 1998;67:150-4.
13. Peng Q, Moan J, Warloe T et al. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol Biol 1996;34:95-6.
14. Fritsch C, Homey B, Stahl W, Lehmann P, Ruzicka T, Sies H. Preferential relative porphyrin enrichment in solar keratoses upon topical application of d-aminolevulinic acid methylester. Photochem Photobiol 1998;68:218-21.
15. Peng Q, Soler AM, Warloe R, Nesland JM, Giercksky K-E. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol Biol 2001;62:140-5.
16. Rud E, Generaas O, Høgset A, Berg K. 5-Aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 2000;71:640-7.
17. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997;79:2282-308.
18. Thissen MR, Schroeter CA, Neumann HAM. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000;142:338-9.
19. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002;146:552-67.
20. Foley J, Freeman M, Siller G, et al. A phase III randomized study comparing photodynamic therapy (PDT) using Metvix® or placebo cream in nodular basal cell carcinoma (BCC). Australas J Dermatol 2003;44:A5.
21. Rhodes LE, de Rie M, Enstrom Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma. Results of a multicenter randomized prospective trial. Arch Dermatol 2004;140:17-23.
22. Basset-Seguin N, Ibbotson S, Emtestam L. Photodynamic therapy using Metvix(r) is as efficacious as cryotherapy in BCC, with better cosmetic results. J Eur Acad Dermatol Venereol 2001;15 (Suppl. 2):226.
23. Pariser DM, Lowe NL, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulate for actinic keratosis. Results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003;48:227-32.
24. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis. A prospective, randomized study. J Am Acad Dermatol 2002;47:258-62.
25. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis. A prospective, randomized study. J Dermatol Treat 2003;4:99-106.
26. Morton CA, Whitehurst C, Moseley H, McColl JH, Moore JV, Mackie RM. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996;135:766-71.
27. Salim A, Leman JA, McColl JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003;148:539-43.
28. Morton C, Horn M, Leman J, et al. A randomized, placebo-controlled European study comparing MAL-PDT with cryotherapy and 5-fluorouracil in subjects with Bowen's disease. Abstract International Skin Conference, Zurich, 2004.
29. Fink-Puches R, Soyer HP, Hofer A, Kerl H, Wolf P. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 1998;134:821-6.
30. Stender IM, Na R, Fogh H, Gluud C, Wulf HC. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 2000;355:963-6.
31. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000;115:183-92.
32. Bissonnette R, Tremblay JF, Juzenas P, Boushira M, Lui H. Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. J Invest Dermatol 2002;119:77-83.
33. Leman JA, Dick DC, Morton CA. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. Clin Exp Dermatol 2002;27:516-8.
34. Paech V, Lorenzen T, Stochr A, et al. Remission of a cutaneous mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection. Eur J Med Res 2002;7:477-9.
35. Umegaki N, Moritsugu R, Katoh S, et al. Photodynamic therapy may be useful in debulking cutaneous lymphoma prior to radiotherapy. Clin Exp Dermatol 2004;20:42-5.
36. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001;145:467-71.
37. Richtlijn behandeling van patiënten met basaalcelcarcinoom. Nederlandse Vereniging voor Dermatologie en Venereologie. Alphen a/d Rijn: Van Zuiden, 2003.
38. Morton CA, Whiteburst C, McColl JH. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma. Arch Dermatol 2001;137:319-24.